FDA inspection

Eli Lilly and Company: FDA inspection ending Feb 26, 2025

FDA inspection 1265205 · No Action Indicated (NAI) · Durham, NC

Key facts

Inspection ID 1265205
Firm Eli Lilly and Company
FEI number 3020952692
Address 59 Moore Dr
City Durham
State NC
ZIP 27709
Fiscal year 2025
Inspection end date Feb 26, 2025
Classification No Action Indicated (NAI)
Project area New Drug Evaluation
Product type Drugs

At a glance

  • None Citations
  • None Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections